Quantum-Si to Participate in the Canaccord Genuity 44th Annual Growth Conference
Quantum-Si (Nasdaq: QSI), known as The Protein Sequencing Company™, has announced its participation in the Canaccord Genuity 44th Annual Growth Conference in Boston from August 13-15, 2024. The company's CEO, Jeff Hawkins, and CFO, Jeff Keyes, will engage in a fireside chat on Tuesday, August 13th, at 11:00 AM ET.
Investors and interested parties can access a live and archived webcast of the event through the 'Investors' section of Quantum-Si's website under Events & Presentations. This participation highlights QSI's commitment to engaging with the investment community and sharing insights about their innovative protein sequencing technology.
Quantum-Si (Nasdaq: QSI), conosciuta come The Protein Sequencing Company™, ha annunciato la sua partecipazione alla 44a Conferenza Annuale sulla Crescita di Canaccord Genuity a Boston dal 13 al 15 agosto 2024. Il CEO dell'azienda, Jeff Hawkins, e il CFO, Jeff Keyes, parteciperanno a un fireside chat martedì 13 agosto alle 11:00 AM ET.
Investitori e soggetti interessati possono accedere a un webcast dal vivo e registrato dell'evento attraverso la sezione 'Investitori' del sito web di Quantum-Si sotto Eventi e Presentazioni. Questa partecipazione sottolinea l'impegno di QSI nel coinvolgere la comunità degli investitori e condividere approfondimenti sulla loro innovativa tecnologia di sequenziamento delle proteine.
Quantum-Si (Nasdaq: QSI), conocida como The Protein Sequencing Company™, ha anunciado su participación en la 44ª Conferencia Anual de Crecimiento de Canaccord Genuity en Boston del 13 al 15 de agosto de 2024. El CEO de la compañía, Jeff Hawkins, y el CFO, Jeff Keyes, participarán en un charla alrededor de la hoguera el martes 13 de agosto a las 11:00 AM ET.
Los inversores y partes interesadas pueden acceder a un webcast en vivo y archivado del evento a través de la sección 'Inversores' en el sitio web de Quantum-Si bajo Eventos y Presentaciones. Esta participación resalta el compromiso de QSI con la comunidad inversora y el propósito de compartir perspectivas sobre su innovadora tecnología de secuenciación de proteínas.
Quantum-Si (Nasdaq: QSI), 단백질 서열 분석 회사로 알려진, 2024년 8월 13일부터 15일까지 보스턴에서 열리는 Canaccord Genuity 제44회 연례 성장 컨퍼런스에 참여한다고 발표했습니다. 회사의 CEO인 Jeff Hawkins와 CFO인 Jeff Keyes는 8월 13일 화요일 오전 11시 ET에 진행되는 화로 주변 대화에 참여할 것입니다.
투자자와 관심 있는 분들은 Quantum-Si 웹사이트의 '투자자' 섹션 하단의 이벤트 및 프레젠테이션 섹션을 통해 이 실시간 및 기록된 웹캐스트에 접근할 수 있습니다. 이번 참여는 QSI가 투자 커뮤니티와의 소통을 통해 혁신적인 단백질 서열 분석 기술에 대한 통찰력을 공유하겠다는 의지를 강조합니다.
Quantum-Si (Nasdaq: QSI), connue sous le nom de The Protein Sequencing Company™, a annoncé sa participation à la 44e Conférence Annuelle de Croissance de Canaccord Genuity à Boston du 13 au 15 août 2024. Le PDG de la société, Jeff Hawkins, et le directeur financier, Jeff Keyes, participeront à une discussion informelle mardi 13 août à 11h00 ET.
Les investisseurs et parties intéressées peuvent accéder à un webinaire en direct et enregistré de l'événement via la section 'Investisseurs' du site Web de Quantum-Si, sous Événements et Présentations. Cette participation souligne l'engagement de QSI à interagir avec la communauté des investisseurs et à partager des idées sur leur technologie innovante de séquençage des protéines.
Quantum-Si (Nasdaq: QSI), bekannt als The Protein Sequencing Company™, hat seine Teilnahme an der 44. jährlichen Wachstums-Konferenz von Canaccord Genuity in Boston vom 13. bis 15. August 2024 bekannt gegeben. Der CEO des Unternehmens, Jeff Hawkins, und der CFO, Jeff Keyes, werden am Dienstag, den 13. August um 11:00 Uhr ET an einem Fireside-Chat teilnehmen.
Investoren und Interessierte können über den Bereich 'Investoren' auf der Website von Quantum-Si auf ein Live- und Archiv-Webcast der Veranstaltung zugreifen, die unter Veranstaltungen & Präsentationen zu finden ist. Diese Teilnahme unterstreicht das Engagement von QSI, mit der Investoren-Community in Kontakt zu treten und Einblicke in ihre innovative Technologie zur Proteinsequenzierung zu teilen.
- None.
- None.
Jeff Hawkins, Quantum-Si's Chief Executive Officer, and Jeff Keyes, Chief Financial Officer, will participate in a fireside chat on Tuesday, August 13th, at 11:00 AM ET.
A live and archived webcast of the event will be available in the “Investors” section of the Quantum-Si website under Events & Presentations.
About Quantum-Si Incorporated
Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable next-generation single-molecule protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at quantum-si.com or follow us on LinkedIn or X.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240730798589/en/
Investor Contact
Doug Farrell, VP, Investor Relations
ir@quantum-si.com
Media Contact
Katherine Atkinson, SVP of Commercial Marketing
media@quantum-si.com
Source: Quantum-Si Incorporated
FAQ
When is Quantum-Si (QSI) participating in the Canaccord Genuity Growth Conference?
Who will represent Quantum-Si (QSI) at the Canaccord Genuity conference?
What time is Quantum-Si's (QSI) fireside chat at the Canaccord Genuity conference?
How can investors access Quantum-Si's (QSI) presentation at the Canaccord Genuity conference?
What is Quantum-Si's (QSI) primary business focus?
